Abstract
The objective of this study was to explore the presentation and management of hypertension secondary to Takayasu arteritis (TA) in a large cohort, single center in China. We retrospectively analyzed 381 TA patients with hypertension hospitalized in Fuwai hospital between Jan. 2004 and Feb. 2014. Diagnosis of hypertension was according to clinic blood pressure or the central blood pressure measured during angiography. Renal artery stenosis was the most common cause (264, 69.3%), followed by the thoracic descending aorta stenosis (98, 25.7%), abdominal aorta stenosis (78, 20.5%), and severe aortic regurgitation (45, 11.8%). More than two kinds of pathologies were found in 98 (25.7%) patients. The mean age of hypertension onset was 25.0 ± 14.3 years. The mean blood pressure of upper extremity in patients without bilateral subclavian artery stenosis (321, 84.3%) was 176.0 ± 29.4 mmHg/97.2 ± 23.0 mmHg, while in 60 (15.7%) patients with bilateral subclavian artery stenosis, the mean central blood pressure was 192.7 ± 30.8 mmHg/102.4 ± 121.1 mmHg. A total of 305 were followed for 38.4 ± 36.7 months, and the rate of blood pressure control, improvement, and failure was 50.8, 41.0, and 8.2%, respectively. Immunosuppressive therapy (OR 2.402, 95% confidence interval 1.253–4.603, P = 0.008) and the pathogenesis of hypertension (P = 0.010) were associated with prognosis of hypertension. The pathogenesis of hypertension due to TA is very complex and multifactorial. Renal artery stenosis is most frequently observed, followed by stenosis of the thoracic descending aorta, abdominal aorta, and severe aortic regurgitation. Immunosuppressive therapy and identifying the pathogenesis of hypertension is of great importance in patients with TA.
Similar content being viewed by others
References
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(2):160–172
Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–S163. https://doi.org/10.1016/S0167-5273(96)02813-6
Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929. https://doi.org/10.7326/0003-4819-120-11-199406010-00004
Goldblatt H, Kahn JR, Hanzal RF (1939) Studies on experimental hypertension: IX. The effect on blood pressure of constriction of the abdominal aorta above and below the site of origin of both main renal arteries. J Exp Med 69(5):649–674. https://doi.org/10.1084/jem.69.5.649
Bonow RO, Carabello B, de Leon AC, Edmunds LH Jr, Fedderly BJ, Freed MD, Gaasch WH, McKay CR, Nishimura RA, O’Gara PT, O’Rourke RA, Rahimtoola SH, Ritchie JL, Cheitlin MD, Eagle KA, Gardner TJ, Garson A Jr, Gibbons RJ, Russell RO, Ryan TJ, Smith SC Jr (1998) ACC/AHA guidelines for the management of patients with valvular heart disease. Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on management of patients with valvular heart disease). J Heart Valve Dis 7(6):672–707
Bekeredjian R, Grayburn PA (2005) Valvular heart disease: aortic regurgitation. Circulation 112(1):125–134. https://doi.org/10.1161/circulationaha.104.488825
Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, Stewart WJ, Waggoner A, Weissman NJ (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16(7):777–802. https://doi.org/10.1016/s0894-7317(03)00335-3
Jain S, Kumari S, Ganguly NK, Sharma BK (1996) Current status of Takayasu arteritis in India. Int J Cardiol 54((suppl) (3)):S111–S116
Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (1977) Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 93(1):94–103. https://doi.org/10.1016/S0002-8703(77)80178-6
Park YB, Hong SK, Choi KJ, Sohn DW, BH O, Lee MM, Yun SC, Seo JD, Lee YW, Park JH (1992) Takayasu arteritis in Korea: clinical and angiographic features. Heart Vessels Suppl 7(1):55–59. https://doi.org/10.1007/BF01744545
Ueda H, Morooka S, Ito I, Yamaguchi H, Takeda T (1969) Clinical observation of 52 cases of aortitis syndrome. Jpn Heart J 10(4):277–288. https://doi.org/10.1536/ihj.10.277
Zheng D, Fan D, Liu L (1992) Takayasu arteritis in China: a report of 530 cases. Heart Vessels Suppl 7(1):32–36
Mammeri A, Guermaz R, Hatri A, Kessal F, Taharboucht S, Hamrour F, Ammi M, Zekri S, Brouri M (2017) Hypertension during Takayasu’s disease: an Algerian single center experience of 279 patients. Annales de cardiologie et d’angeiologie 66(3):154–158. https://doi.org/10.1016/j.ancard.2017.04.006
Evan F, Daniel A, Terri F (2003) Hypertension and elevated ESR as diagnostic features of Takayasu arteritis in children. J Clin Rheumatol 9(3):156–163
Hmida B, Maazoun, Marzouk, Frigui, Bouattour, Chaabouni, Salah B, Kacem, Kaddour, Bahloul (2010) Hypertension in Takayasu disease: Pp.15.72. J Hypertens 28 (28):e270
Laurent A, Julien H, Nicolas L, Dan T, Laetitia G, Nathalie CC, LTHB D, Patrice C, Philippe C, Fabien K (2010) Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine 89(1):1–17
Maksimowicz-Mckinnon K, Clark TM, Hoffman GS (2007) Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 56(3):1000–1009. https://doi.org/10.1002/art.22404
Mwipatayi BP, Jeffery PC, Beningfield SJ, Matley PJ, Naidoo NG, Kalla AA, Kahn D (2005) Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 75(3):110–117. https://doi.org/10.1111/j.1445-2197.2005.03312.x
Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu’s arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 34(4):284–292. https://doi.org/10.1080/03009740510026526
Sato EI, Lima D, Santo BE, Hata F (2000) Takayasu arteritis. Treatment and prognosis in a university center in Brazil. Int J Cardiol 75((suppl1) (9)):S163–S166
Vanoli M, Daina E, Salvarani C, Sabbadini MG, Rossi C, Bacchiani G, Schieppati A, Baldissera E, Bertolini G (2005) Takayasu’s arteritis: a study of 104 Italian patients. Arthritis Rheum 53(1):100–107. https://doi.org/10.1002/art.20922
Peng M, Jiang XJ, Dong H, Zou YB, Zhang HM, Song L, Li B, Yang YJ, HY W, Gao RL, Zhang WG, Liu LS (2016) Etiology of renal artery stenosis in 2047 patients: a single-center retrospective analysis during a 15-year period in China. J Hum Hypertens 30(2):124–128. https://doi.org/10.1038/jhh.2015.40
Petrovic-Rackov L, Pejnovic N, Jevtic M, Damjanov N (2009) Longitudinal study of 16 patients with Takayasu’s arteritis: clinical features and therapeutic management. Clin Rheumatol 28(2):179–185. https://doi.org/10.1007/s10067-008-1009-7
Ueda H, Sugiura M, Ito I, Saito Y, Morooka S (1967) Aortic insufficiency associated with aortitis syndrome. Jpn Heart J 8(2):107–120. https://doi.org/10.1536/ihj.8.107
Akikusa B, Kondo Y, Muraki N (1981) Aortic insufficiency caused by Takayasu’s arteritis without usual clinical features. Arch Pathol Lab Med 105(12):650–651
Isomura T, Hisatomi K, Yanagi I, Shimada S, Uraguchi K, Aoyagi S, Kosuga K, Ohishi K (1988) The surgical treatment of aortic regurgitation secondary to aortitis. Ann Thorac Surg 45(2):181–185. https://doi.org/10.1016/S0003-4975(10)62433-2
Roberts WC, Ko JM, Moore TR, Jones WH 3rd (2006) Causes of pure aortic regurgitation in patients having isolated aortic valve replacement at a single US tertiary hospital (1993 to 2005). Circulation 114(5):422–429. https://doi.org/10.1161/circulationaha.106.622761
Kaoru M, Hitoshi O, Junjiro K, Hatsue IU, Hitoshi M, Kenji M, Hiroaki S, Ko B, Kazuo N, Osamu T (2005) Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality. Circulation 112(24):3707–3712
Milner LS, Jacobs DW, Thomson PD, Kala UK, Franklin J, Beale P, Levin SE (1991) Management of severe hypertension in childhood Takayasu’s arteritis. Pediatr Nephrol 5(1):38–41. https://doi.org/10.1007/BF00852840
de Souza AW, Machado NP, Pereira VM, Arraes AE, Reis Neto ET, Mariz HA, Sato EI (2010) Antiplatelet therapy for the prevention of arterial ischemic events in Takayasu arteritis. Circ J 74(6):1236–1241. https://doi.org/10.1253/circj.CJ-09-0905
Ito I (1992) Medical treatment of Takayasu arteritis. Heart Vessels Suppl 7(7):133–137. https://doi.org/10.1007/BF01744559
Kulkarni TP, D’Cruz IA, Gandhi MJ, Dadhich DS (1974) Reversal of renovascular hypertension caused by nonspecific aortitis after corticosteroid therapy. Heart 36(1):114–116. https://doi.org/10.1136/hrt.36.1.114
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The study protocol was approved by the Institutional Ethics Committee of Fuwai Hospital (No. 2016-842).
Disclosures
None.
Rights and permissions
About this article
Cite this article
Qi, Y., Yang, L., Zhang, H. et al. The presentation and management of hypertension in a large cohort of Takayasu arteritis. Clin Rheumatol 37, 2781–2788 (2018). https://doi.org/10.1007/s10067-017-3947-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3947-4